After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms.

There are two trials that I think are probably the most excited about. One of them is called the PEAK trial, and it was a ...

Our experts can talk with you about whether a clinical trial is right for you. Clinical trials are research studies to test promising new treatments, procedures, or devices. Some even look at ways to ...

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...

Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer's drug—are poised ...

North Carolina-based CRO WEP Clinical is bolstering its global offerings with the acquisition of European CRO Siron Clinical.

The PanCAN Patient Services team is here for patients and their loved ones as they navigate clinical trials. Our Case Managers offer personal, one-to-one support at every step of the search and ...

Allucent has strategically added executives to its C-suite and is deploying artificial intelligence tools to help small and ...